# Boswellia Osteoarthritis Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/boswellia-osteoarthritis-meta-analysis-evidence-review
Category: evidence-review
Summary: Boswellia Osteoarthritis Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are 
Last reviewed: 2026-05-20
Reviewed by: Migaku Evidence Review
# Boswellia Osteoarthritis Meta-analysis: What the Evidence Says

## Quick Answer

Boswellia Osteoarthritis Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis | systematic review | 1 | 2025-08-03 | 10.3390/nu17152547 |
| Nutritional Interventions in Osteoarthritis: Mechanisms, Clinical Evidence, and Translational Opportunities | narrative review | 3 | 2026-01-13 | 10.3390/nu18020244 |

## What The Sources Report

- However, prolonged NSAID use is associated with various adverse effects, including gastrointestinal complications, cardiovascular disease, and potential renal and hepatic toxicity. [Zhang Yuntong (2025); evidence level 1]
- As a result, many patients with KOA seek alternative or non-pharmacological therapies to relieve pain and functional impairment. [Zhang Yuntong (2025); evidence level 1]
- Between 1990 and 2020, OA prevalence increased by over 100%, and the years lived with disability (YLDs) have also risen sharply, creating a substantial economic burden on patients and healthcare systems. [Patel Milan (2026); evidence level 3]
- Risk factors such as age, obesity, prior joint injury, and genetics drive this alarming upward trend, especially obesity, as it accounts for a growing fraction of the OA burden worldwide. [Patel Milan (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For boswellia osteoarthritis meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Zhang Yuntong (2025). Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis. DOI: 10.3390/nu17152547. PMCID: PMC12348802. PMID: 40806131. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12348802/
- Patel Milan (2026). Nutritional Interventions in Osteoarthritis: Mechanisms, Clinical Evidence, and Translational Opportunities. DOI: 10.3390/nu18020244. PMCID: PMC12844890. PMID: 41599857. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12844890/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.